Crescent Capital BDC, Inc. Reports Third Quarter 2026 Earnings Results; Declares a Fourth Quarter Base Dividend of $0.34 Per Share and Announces a $50 Million Share Repurchase Program

Crescent Capital BDC posts stable Q3 results, announces $75 million in buyback plans.

What the company is saying

Crescent Capital BDC, Inc. reports net investment income of $0.37 per share and net income of $0.27 per share for the quarter ended September 30, 2026. The company highlights a net asset value per share of $17.72 and details its portfolio composition, with 190 portfolio companies and investments at fair value totaling $1,555.2 million. The Board has declared a regular Q4 cash dividend of $0.34 per share, payable January 15, 2027, and a final $0.03 per share special dividend to be paid December 15, 2026. The announcement emphasizes capital return to shareholders, with a newly authorized $50 million share repurchase program and Sun Life's plan to purchase up to $25 million of common stock in the open market. The company frames its results as stable, noting a weighted average yield on income-producing securities of 9.6% and a portfolio heavily weighted to unitranche first lien loans. Management attributes a modest increase in investment income to higher recurring interest income from increased benchmark rates, while dividend income declined due to lower Logan JV distributions.

What the data suggests

The company generated $36.9 million in investment income and $13.7 million in net investment income for the quarter, with net realized losses of $(2.1) million and net unrealized losses of $(1.5) million, resulting in a $10.1 million net increase in net assets from operations. Net asset value per share declined to $17.72, and total net assets fell to $652.9 million. Portfolio activity was moderate, with $23.5 million invested in new and follow-on deals and $38.7 million in exits and repayments. The portfolio remains concentrated in unitranche first lien loans (65.3%) and senior secured first lien (24.2%), with 98.2% of debt investments at floating rates. The company maintains $36.2 million in cash and $210.5 million in undrawn credit, with a net debt-to-equity ratio of 1.36x and a weighted average cost of debt of 6.26%. Dividend coverage appears adequate, with $0.34 per share in regular and $0.03 per share in special dividends declared for Q4. The $50 million buyback and Sun Life's $25 million planned purchase represent significant potential support for the stock, but neither has yet been executed. The figures suggest stable but not growing profitability, with realized and unrealized losses offsetting income gains.

Analysis

The announcement is a standard quarterly financial disclosure, presenting realised results for the period ended September 30, 2026, including net investment income, net income, NAV, and detailed portfolio data. The only forward-looking claim is Sun Life's plan to purchase up to $25 million of stock, which is clearly identified as a plan rather than a completed action. The share repurchase program is authorized but not yet executed, and both actions represent significant capital allocation with benefits (EPS accretion, share support) that will materialize only as the programs are carried out. However, the language is factual and proportionate, with no exaggerated claims or promotional tone. All other key claims are realised and supported by disclosed figures. The absence of comparative or trend data limits the ability to assess improvement, but the completeness of current-period disclosure is strong.

Risk flags

• ●Net asset value per share has declined to $17.72, with total net assets falling to $652.9 million, indicating pressure on book value that may reflect portfolio markdowns or realized/unrealized losses.
• ●The company reported net realized and unrealized losses totaling $(3.6) million for the quarter, which, if persistent, could erode capital and limit future dividend capacity.
• ●The announced $50 million share repurchase program and Sun Life's $25 million planned purchase are not yet executed; the timing, scale, and market impact of these actions remain uncertain and may not fully materialize.
• ●A high net debt-to-equity ratio of 1.36x and a weighted average cost of debt of 6.26% expose the company to refinancing and interest rate risk, especially if portfolio yields decline or credit conditions tighten.
• ●Dividend income decreased due to lower distributions from the Logan JV, highlighting potential volatility in non-interest income streams that could affect overall earnings stability.

Bottom line

Crescent Capital BDC's Q3 2026 results show stable net investment income and continued dividend payments, but net asset value per share and total net assets have declined, reflecting realized and unrealized losses. The portfolio remains heavily weighted to floating-rate, unitranche first lien loans, providing some protection against rate changes but also concentration risk. The newly authorized $50 million share repurchase program and Sun Life's $25 million planned open market purchase could offer share price support, but their impact will depend on actual execution. The company's leverage remains high, and declining dividend income from JV investments adds a note of caution. Investors should focus on the realization of buyback activity, future portfolio performance, and the sustainability of dividend coverage given ongoing losses. The most important takeaway is that while capital return initiatives are positive, underlying portfolio and NAV trends warrant close monitoring.

Announcement summary

(NASDAQ:CCAP) Crescent Capital BDC, Inc. reported net investment income of $0.37 per share and net income of $0.27 per share for the quarter ended September 30, 2026. Net asset value (NAV) per share was $17.72 at September 30, 2026. The Board of Directors declared a fourth quarter 2026 regular cash dividend of $0.34 per share to stockholders of record as of December 31, 2026, payable on January 15, 2027. The third and final previously announced $0.03 per share special dividend will be paid on December 15, 2026 to stockholders of record as of November 30, 2026. On November 5, 2026, the Board authorized a share repurchase program of up to $50 million of the Company’s common stock, to be executed by an independent third-party broker under a Rule 10b5-1 trading plan. Sun Life plans to purchase up to an additional $25 million of the Company’s common stock in the open market through an independent third-party broker under a Rule 10b5-1 trading plan. As of September 30, 2026, investments at fair value totaled $1,555.2 million, total assets were $1,601.4 million, and total net assets were $652.9 million. Net asset value per share was $17.72, investment income was $36.9 million, and net investment income was $13.7 million for the quarter. Net realized losses, net of taxes, were $(2.1) million, and net change in unrealized losses, net of taxes, was $(1.5) million. Net increase in net assets resulting from operations was $10.1 million. Regular distributions paid per share were $0.34 and special distributions paid per share were $0.03. The weighted average yield on income producing securities (at cost) was 9.6%, and 98.2% of debt investments were at floating rates. As of September 30, 2026, the Company had investments in 190 portfolio companies with an aggregate fair value of $1,555.2 million. The portfolio at fair value consisted of $375.8 million (24.2%) in senior secured first lien, $1,015.8 million (65.3%) in unitranche first lien, $18.5 million (1.2%) in unitranche first lien - last out, $14.4 million (0.9%) in senior secured second lien, $28.8 million (1.9%) in unsecured debt, $73.5 million (4.7%) in equity & other, and $28.4 million (1.8%) in LLC/LP equity interests. For the quarter ended September 30, 2026, the Company invested $23.5 million across three new portfolio companies and several follow-on revolver and delayed draw fundings, and had $38.7 million in aggregate exits, sales and repayments. Interest income for the quarter was $35.6 million, including $0.5 million of accelerated OID amortization related to investment repayments. Dividend income was $0.9 million, and other income was $0.4 million. Total net expenses, including income and excise taxes, were $23.2 million. As of September 30, 2026, the Company had $36.2 million in cash and cash equivalents and restricted cash, and $210.5 million of undrawn capacity on its credit facilities. The weighted average cost of debt on debt outstanding was 6.26%, and the net debt-to-equity ratio was 1.36x. As of September 30, 2026, non-controlled non-affiliated investments at fair value were $1,465,353, non-controlled affiliated investments were $30,884, and controlled investments were $58,915. Cash and cash equivalents were $12,081, and restricted cash and cash equivalents were $24,123. Total assets were $1,601,447, and total liabilities were $948,515. Common stock issued and outstanding was 36,845,952 shares. Paid-in capital in excess of par value was $955,363, and accumulated earnings (loss) were $(302,468). Net asset value per share was $17.72. For the three months ended September 30, 2026, total investment income was $36,886, expenses were $22,959, and net investment income before taxes was $13,929. Provision for income and excise taxes was $238, and net investment income was $13,691. Net realized and unrealized losses on investments were $(3,577). Net increase in net assets resulting from operations was $10,114. Net increase in net assets resulting from operations per share (basic and diluted) was $0.27, and net investment income per share (basic and diluted) was $0.37. Weighted average shares outstanding (basic and diluted) were 36,845,952.

Disagree with this article?